Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation

Edward Y. Woo(University of Pennsylvania), Heidi Yeh(University of Pennsylvania), Christina Chu(University of Pennsylvania), Katia Schlienger(Cancer Research Institute of the Slovak Academy of Sciences), Richard G. Carroll(Cancer Research Institute of the Slovak Academy of Sciences), James L. Riley(Cancer Research Institute of the Slovak Academy of Sciences), Larry R. Kaiser(University of Pennsylvania), Carl H. June(Cancer Research Institute of the Slovak Academy of Sciences)
The Journal of Immunology
May 1, 2002
Cited by 696Open Access
Full Text

Abstract

Active suppression by T regulatory cells plays an important role in the down-regulation of T cell responses to foreign and self-Ags. Thus far, the potential role of CD4(+)CD25(+) T cells in human tumors has not been reported. In this work we show that lung tumors contain large numbers of these cells and that they have constitutive high-level expression of CD152 (CTLA-4). Furthermore, the CD4(+)CD25(+) T cells mediate potent inhibition of autologous T cell proliferation. Finally, regulatory T cells from patient tumors failed to inhibit the proliferation of allogeneic T cells. Together these results suggest that the CD4(+)CD25(+) T cells found in lung tumors selectively inhibit the host immune response and therefore could contribute to the progression of lung cancer.


Related Papers